Clinical and Histologic Characteristic of Renal Parenchymal Diseases in a Renal Biopsy Sample since 2002 to 2017 in Caldas - Colombia
PDF (Español)
HTML (Español)


Kidney diseases

How to Cite

García Herrera HG, Restrepo Valencia CA, Buitrago Villa CA. Clinical and Histologic Characteristic of Renal Parenchymal Diseases in a Renal Biopsy Sample since 2002 to 2017 in Caldas - Colombia. Rev. Colomb. Nefrol. [Internet]. 2018 Aug. 9 [cited 2024 Jul. 18];5(2):107-1. Available from:


Background: Renal syndromes are clinical and laboratory manifestations that indicate functional and morphological alterations. Renal biopsy is essential in the diagnosis of kidney parenchymal diseases and provides valuable information in incidence, distribution and possible control of the disease.

Objective: To describe the clinical and histological characteristics of renal parenchymal diseases in a sample of renal biopsies.

Methods: We included 269 patients older than 14 years who underwent renal biopsy by any method. They were classified by indication of biopsy and by type of primary or secondary kidney injury.

Results: The average age was 57,04 (SD ± 17,17 years). The median creatinine was 1,51 mg / dL (RIC=1,22 - 2,01) and the GFR for CKDEPI was 42,7 mil/minute (RIC=30,6 - 56,5). The most frequent renal biopsy indications were unexplained chronic kidney disease (46,8 %), non-nephrotic proteinuria (20,1 %), nephritic syndrome (8,2 %), acute kidney injury (7,1 %), glomerular hematuria with change in the pattern (7,1 %), nephrotic syndrome (6,7 %) and unexplained low glomerular filtration for age (4,1 %). The most frequent finding were IgA nephropathy (20,9 %), hypertensive nephropathy (19 %), focal and segmental glomerulosclerosis (11,6 %), tubulointerstitial nephritis (9,7 %), diabetic glomerulopathy (8,6 %), membranoproliferative glomerulonephritis (3,7 %), extracapillary proliferative glomerulonephritis (3,4 %).

Conclusions: IgA nephropathy and focal segmental glomerulosclerosis are the main primary glomerulopathies. Hypertensive nephropathy and tubulointerstitial nephritis are the main secondary etiologies.
PDF (Español)
HTML (Español)


1. Restrepo CA, Buitrago CA, Torres J, Serna J. Nefrología básica 2. Manizales: Editorial La Patria; 2012.

2. Dhaun N, Bellamy CO, Cattran D, Kluth DC. Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014;85(5):1039-1048.

3. Ismail MI, Lakouz K, Abdelbary E. Clinicopathological correlations of renal pathology: A single center experience. Saudi J Kidney Dis Traspl. 2016;27(3):557-562.

4. Bomback AS, Herlitz LC, Markowitz GS. Renal biopsy in the elderly and very elderly: useful or not?. Adv Chronic Kidney Dis. 2012;19(2):61-67.

5. Carrilho-Mota P. Indicaçoes actuáis para biopsia renal. Acta Med Port. 2005;18(2):147-151.

6. Imitiaz S, Nasir K, Drohlia MF, Salman B, Ahmad A. Frecuency of kidney diseases and clinical indications of pediatric renal biopsy: A single center experience. Indian J Nephrol. 2016;26(3):199-205. https://doi.org10.4103/0971-4065.159304

7. Matsushita K, Mahmoodi B, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKDEPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941-1951.

8. Papadakis MA, Mcphee S. Current Medical Diagnosis & Treatment 2017. New York: McGraw Hill; 2017.

9. Sim JJ, Batech M, Hever A, Harrison TN, Avelar T, Kanter MH, et al. Distribution of biopsy proven presumed primary glomerulonephropathies in 2000-2011 among a racially and ethnically diverse US population. Am J Kidney Dis. 2016;68(4):533-544.

10. Woo KT, Chan CM, Chin YM, Choong HL, Tan HK, Foo M, et al. Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract. 2010;116(4):c337-c346.

11. Korbet SM, Genchi RM, Borok RZ, Schwartz MM. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis. 1996;27(5):647-651.

12. Nair R, Bell JM, Walker PD. Renal biopsy in patients aged 80 years and older. Am J Kidney Dis. 2004;44(4):618-626.

13. Arenas PG, Diller A, Orias M, Arteaga J, Douchat W, Massari P. Biopsias renales: frecuencia, indicaciones y resultados actuales en un centro hospitalario. Nefrología Argentina. 2005;3(2):55-65.

14. Hurtado A, Escudero E, Stronquist CS, Urcia J, Hurtado ME, Gretch D, et al. Distinct patterns of glomerular disease in Lima, Perú. Clin Nephrol. 2000;53:325-332.

15. Cruz HM, Penna D de O, Saldanha LB, Cruz J, Luiz P, Marcondes M, et al. Histopathologic study of primary glomerulopathies: retrospective analysis of 197 renal biopsies (1985-1987). Rev Hosp Clin Fac Med Sao Paulo. 1989;44(3):94-99.

16. Mejia G, Builes M, Arbelaez M, Henao JE, Arango JL, Garcia A. Descripción clinicopatológica de las enfermedades glomerulares. Acta Med Colomb. 1989;14(6):369-374.

17. Gómez-Jiménez JM, Arias LF. Enfermedades glomerulares durante la gestación. Serie de casos y revisión de la literatura. Revista Colombiana de obstetricia y Ginecología. 2008;59(4):343-348.

18. Serna-Florez J, Torres-Saltarín J, Serrano-Mass D. Enfermedades renales diagnósticadas por biopsia: descripción clínica, histológica y epidemiológica. Resultados de la población atendida entre 1992 y 2010 en el servicio de nefrología del Hospital Universitario San Juan de Dios. Armenia (Colombia). Méd UIS.2011;24(1):39-43.

19. Coronado CY, Echeverry I. Descripción clínicopatológica de las enfermedades glomerulares. Acta MedColomb. 2016:41(2):125-129.

20. McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414-430.

21. Rodrigues JC, Haas M, Reich HN. IgA Nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677-686.

22. Freedman BI, Iskander SS, Buckalew VM Jr, Burkart JM, Appel RG. Renal biopsy findings in presumed hypertensive nephrosclerosis. Am J Nephrol. 1994;14(2):90-94.

23. Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol. 2009;4:1073-1082.

24. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004;44(5):815-825.

25. De Broe ME, Elseviers MM. Over-the-counter analgesic use. J Am Soc Nephrol. 2009;20(10):2098-2103.

26. Tang SC, Chan GC, Lai KN. Recent advances in managing and understanding diabetic nephropathy. F1000Res. 2016;5.

27. Aristizábal Gómez LY, Restrepo Valencia CA., Aguirre Arango JV. Clinical characteristic of a population of diabetics type 2 with alteration in the renal function non macroalbuminuric. Rev Colomb Nefrol. 2017;4(2):149-158.
No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.




Download data is not yet available.